The Claim

In adults with bipolar depression, adjunctive creatine monohydrate at 6 g daily for 6 weeks was associated with a 66.7% remission rate among treatment completers compared to 18.2% in placebo completers, but this finding was not replicated in the primary outcome of mean MADRS score change, suggesting potential bias from selective attrition.

Source: A randomized, double-blind, placebo-controlled, proof-of-concept trial of creatine monohydrate as adjunctive treatment for bipolar depression

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
75score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

Correlation
1 study reviewed
In plain English

In adults with bipolar depression, taking 6 grams of creatine monohydrate daily for six weeks was linked to a higher rate of remission among those who completed the treatment compared to those who took a placebo, but this difference was not seen in the main measure of depression severity, indicating possible bias due to participants dropping out.

See the scientific wording

In adults with bipolar depression, adjunctive creatine monohydrate at 6 g daily for 6 weeks was associated with a 66.7% remission rate among treatment completers compared to 18.2% in placebo completers, but this finding was not replicated in the primary outcome of mean MADRS score change, suggesting potential bias from selective attrition.

Why this might work

Creatine enters the brain and helps produce more energy for nerve cells by replenishing a key fuel molecule, while also neutralizing harmful chemicals that damage cells. This improves how well nerve cells communicate and survive in brain areas that control mood, leading to a reduction in depressive symptoms.

Supported mechanismbased on 1 study

What the research says

1 study

  1. Study: A randomized, double-blind, placebo-controlled, proof-of-concept trial of creatine monohydrate as adjunctive treatment for bipolar depression

    In a small study, people with bipolar depression who took creatine and finished the treatment were much more likely to feel much better than those who took a placebo — but more people dropped out of the placebo group, so it’s not totally clear if creatine really caused the improvement.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.